Masaru Matsuda sold $1.4M of Arcutis Biotherapeutics stock
By AlphaYouPublished Form 4
Matsuda Masaru
Reporting filer
Masaru Matsuda reported selling 41,219 shares of Arcutis Biotherapeutics, Inc. for about $1.4M ($34.24 a share on average). Form 4 filed Nov 4, 2026 lists 4 entries.
- Disclosed
- Nov 4, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Matsuda Masaru | 2026-11-02 | S | Sale | 1219 | 31.8634 | 111,289 | 2 days | Filed terms
|
| Common Stock | Matsuda Masaru | 2026-11-04 | M | Exercise or conversion | 40000 | 3.64 | 151,289 | 0 days | Filed terms
|
| Common Stock | Matsuda Masaru | 2026-11-04 | S | Sale | 40000 | 34.3168 | 111,289 | 0 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Matsuda Masaru | 2026-11-04 | M | Exercise or conversion | 40000 | 0 | 136,000 | 0 days | Filed terms
|
Common Stock
- Owner
- Matsuda Masaru
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 1219
- Price
- 31.8634
- Following holdings
- 111,289
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1219
- transaction Price Per Share: 31.8634
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 111289
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Matsuda Masaru
- Date
- 2026-11-04
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 40000
- Price
- 3.64
- Following holdings
- 151,289
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F3
- transaction Shares: 40000
- transaction Price Per Share: 3.64
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 151289
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Matsuda Masaru
- Date
- 2026-11-04
- Code
- S
- Action
- Sale
- Quantity
- 40000
- Price
- 34.3168
- Following holdings
- 111,289
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F3
- transaction Shares: 40000
- transaction Price Per Share: 34.3168
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 111289
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Matsuda Masaru
- Date
- 2026-11-04
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 40000
- Price
- 0
- Following holdings
- 136,000
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 3.64
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F3
- transaction Shares: 40000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F5
- expiration Date: 2034-01-12
- underlying Security Title: Common Stock
- underlying Security Shares: 40000
- shares Owned Following Transaction: 136000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Matsuda Masaru: EVP, Chief Legal Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3: The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027.
- F4: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $34.00 to $37.7966, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.